Movatterモバイル変換


[0]ホーム

URL:


US3249109A - Topical dressing - Google Patents

Topical dressing
Download PDF

Info

Publication number
US3249109A
US3249109AUS320809AUS32080963AUS3249109AUS 3249109 AUS3249109 AUS 3249109AUS 320809 AUS320809 AUS 320809AUS 32080963 AUS32080963 AUS 32080963AUS 3249109 AUS3249109 AUS 3249109A
Authority
US
United States
Prior art keywords
base
dressing
gelatin
backing member
pectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US320809A
Inventor
Maeth Harry
Pennings Ralph David
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to US320809ApriorityCriticalpatent/US3249109A/en
Application grantedgrantedCritical
Publication of US3249109ApublicationCriticalpatent/US3249109A/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Description

Ma 3, 1966 H. MAETH ETAL 3,249,109
TORI CAL DRESS ING Filed Nov. 1, 1963 HARRY MA ETH R. DAVID PENNINGS BY Vndrus 9f Star/ 52 A'f-ronwsvs INVENTORS United States Patent 3,249,109 TOPICAL DRESSING Harry Maeth, 101 Main, and Ralph David Pennings, 302 Main, both of Mosinee, Wis. Filed Nov. 1, 1963, Ser. No. 320,809 9 Claims. (Cl. 128-268) This invention relates to a pharmaceutical preparation and more particularly to a pharmaceutical preparation for topical application to mucous membranes.
It is often desired to apply a dressing to the mucous membranes of the body, such as the oral cavity. For example, it may be desired to apply a post-operative dressing following gum surgery, or to use a dressing for intraoral traumatic wounds. In the past, dressings to be used in the oral cavity were generally made of tinfoil and included a base plate material which required heat to adapt it to its position on the membrane. If the dessing included a medicament or therapeutic agent, leakage of the agent generally occurred and could not be controlled. This resulted in the incomplete application of the agent to the site of treatment and dispersion of the agent into the mouth and possible entry into the alimentary tract.
The present invention is directed to an adhesive dressing to be topically applied to the body and in particular to the mucous membranes, such as the oral cavity. More specifically, the dressing or pharmaceutical preparation includes a flexible adhesive base composed of hydrated gelatin and including a small amount of pectin. In addition, a medicament or therapeutic agent can be incorporated in the flexible base. The base material is applied to the membrane at the site of the treatment and will adhere to the moist membrane. To prevent loss of the medicament or therapeutic agent, a backing member is applied to the outer surface of the flexible base. The backing member may take the form of a generally inert fabric, such as glass fibers, muslin or the like.
The hydrated gelatin base, which serves as the vehicle for the medicament or therapeutic agent, is flexible and is very adhesive and will readily adhere to the surfaces of the oral cavity or other mucous membranes. The gelatin base will remain flexible for extended periods of time and will not crack or chip. Moreover, the base does not contain oils or essential oils which can be irritating or toxic to the patient.
The use of the fabric backing layer insures theproper dosage of the medicament or therapeutic agent and prevents the dispersion of the agent from the site of treatment, thereby preventing the dispersion of the agent into the mouth and possible entry into the alimentary tract.
The pharmaceutical preparation or dressing can be used as a post-operative dressing in gum surgery, as a dressing for intraoral traumatic wounds, for the management of soft tissue lesions in the mouth, and as an irradiation shield for the treatment of malignant conditions with X-ray. In addition, it can also be used for topical application to the skin for abrasions, burns, varicose ulcers, and the like.
Other objects and advantages will appear in the course of the following description.
The drawings illustrate the best mode presently contemplated of carrying out the invention.
In the drawings:
FIG. 1 is a perspective view of a dressing prepared in accordance with the invention;
I FIG. 2 is a modified form of the invention showing the dressing in the form of a roll; and
FIG. 3 is a second modified form of the invention showing the dress-ing in the form of a pre-cut strip.
3,249,109 Patented May 3 1966 FIG. 1 shows a dressing 1 to be used for topical applications and particularly to the mucous membranes of the body. The dressing has particular application to the mucous membranes of the oral cavity, but also includes other areas such as the vagina, rectum, etc.
The dressing 1 includes a flexiblehydrated gelatin base 2 and a fabric backing member 3. Thehydrated gelatin base 2 contains by weight, 10 to 40% gelatin, 5 to Water, 15 to 80% polyhydric alcohol and up to 15% pectin.
The preferred range of composition, in weight percent is as follows:
Percent Gelatin 1033 Water 50-85 Polyhydric alcohol 15-35 Pectin 1-4 The hydrated gelatin gives the base its consistency and bulk and serves as the vehicle for the incorporation of medicaments and therapeutic agents.
Pectin is a carbohydrate obtained from the dilute acid extract of the inner portion of the rind of citrus fruits or apple peel. Pectin consists chiefly of partially methoxylated polygalacturonic acids.
The pectin provides adhesive properties to the hydrated gelatin and enables the gelatin base to be readily applied to moist surfaces, such as the mucous membranes.
The polyhydric alcohol serves to prevent brittleness and retains the flexible characteristics of the material for extended periods. The polyhdric alcohol can be glycerin, polyoxyethylene, propylene glycol, sorbitol, ethylene glycol (when used externally), and the like.
It is also contemplated that thebase 2 will include a pharmacologically active material such as a medicament or a therapeutic agent. More specifically, the pharmacologically active material may include enzymes such as hyaluronidase; vasoconstrictors such as epinephrine; bactericides; bacteristatics; antacids; anesthetics; corticosteroids; antibiotics; hemostats; fluorides such as sodium fluoride, stannous fluoride, calcium fluoride; astringents, hormones; vitamins; tissue growth promoters such as Peruvian balsam; deodorants such as charcoal, and chlorophyll, and the like. The pharmacologically active material is used in an amount up to 10% by weight of the composition with the particular amount depending on the activity of the material.
The backing member 3 is formed of an inert, non toxic fibrous material such as glass fiber, muslin and the like. The use of glass fiber cloth has proven particularly satisfactory as a reinforcement and as a dam to reduce the spreading of the pharmacologically active material bility and a marked resistance to steam, corrosive fumes and most acids. In addition, the glass fiber will not absorb water and can be readily sterilized and re-sterilized and withstands repeated folding and creasing.
The fabric backing member 3 serves as a barrier and assures that the proper dosage of the medicament or therapeutic agent is supplied to the site to be treated. The backing member 3 prevents the agent from being dispersed into the mouth and prevents the entry of the agent into the alimentary tract.
To prepare the dressing of the invention, the gelatin and a portion of the Water and glycerin are mixed at an elevated temperature of about C. to form a gelatin component. ing portion of the water and glycerin to form a pectin component which is then added to the heated gelatin component. In some cases it may be desirable to add a The pectin is then mixed with the remainsmall amount, in the range of 1 to 2% of the total composition weight, of alcohol, such as ethyl alcohol, to the pectin component. The alcohol provides a rapid hydration of the pectin and can be omitted, but, if omitted, increases the time required for preparation.
After adding the pectin component to the gelatin component, the medicament or therapeutic agent is added as a solution or suspension, depending upon the particular agent used. The entire composition is then agitated to thoroughly mix the components and is subsequently poured into the desired mold and cooled. The backing member 3 is then overlayed onto the base material.
Example 1 As a specific example of the preparation, 30 grams of gelatin, 30 cc. of distilled water and 30 cc. of glycerin were mixed together and heated to a temperature of 90 C. to melt the gelatin. After the gelatin was melted, the pectin component consisting of 5 cc. of ethyl alcohol, 40 cc. of distilled water, cc. of glycerin and 5 grams of pectin was added to the liquid gelatin component and mixed therewith.
After adding the pectin component, 8 grams of Benzocaine and 40 cc. of alcohol, and 0.5 gram of Triburon (triclobisonium chloride) in 10 cc. of distilled water were added to the composition. After mixing in the Benzocaine and Triburon, the composition was poured into a mold and cooled. A glass fiber backing sheet was then overlayed over the composition and pressed firmly therein.
The resulting dressing was flexible and very adhesive and could readily be applied to mucous membranes.
Example 2 Three grams of pectin, 10 cc. of ethyl alcohol, 80 cc. of distilled water and 40 cc. of glycerin were mixed together. Forty grams of gelatin were added to this mixture and the entire composition heated to a temperature of 90 to 100 C. to melt the gelatin. Subsequently, 0.25
gram of Triburon in 17 cc. of glycerin and 20 cc. of distilled water were added to the gelatin-pectin composition. The resulting composition was then poured onto a suitable mold and cooled.
FIG. 2 shows a modified form of the invention in which the dressing is in strip form. In this embodiment the dressing includes a hydrated gelatin base 4 similar in composition togelatin base 2 of the first embodiment. A fabric backing member 5 is applied to one surface of the base 4 and the backing member 5 is similar in structure and function to the backing member 3 of the first embodiment. In addition, a protective strip of material, such as waxed paper or other material, is applied to the outer surface of the barrier and serves to prevent the strip from sticking to itself when it is wound in spiral form.
The strip shown in FIG. 2 can be unwound as desired and cut to any length, depending on the nature of the site to be treated.
FIG. 3 shows a second modified form of the invention in which the dressing is in the form of a pre-cut strip. In this embodiment, the hydrated gelatin base 7, similar tobase 2 of the first embodiment, is applied to an adhesive backing member 8. In this embodiment, a protective strip of material is applied to the adhesive surface of the strip 8 and can be removed immediately prior to application of the strip to the body surface.
The dressing of the invention is used for topical application, and particularly to the moist mucous membranes. For example, the dressing can be used as a post-operative dressing following surgery, as a dressing for traumatic wounds, 'as a dressing for soft tissue lesions and it also may be employed as an irradiation shield for the treatment of malignant conditions with X-ray. In this lattercase, a radiation barrier, such as powdered lead or barium sulphate, can be incorporated in theflexible base 2 in an amount of about 10 to 30% by weight of the base. The lead or barium sulphate is radiopaque material and serves as an irradiation shield to protect structures such as teeth and soft tissues from the radiation. This type of barrier is considerably more flexible and pliable than sheet lead for intraoral use, and being a lightweight material, is exceedingly more comfortable to the patient.
The dressing of the invention is flexible and will tightly adhere to moist membrane surfaces. If the dressing is to be applied to the external body tissues, it may be necessary to moisten the tissue before application.
It is contemplated that pharmacologically active materials can be incorporated in the hydrated gelatin base and the backing member serves to concentrate the activity of the material at the site of treatment and prevents the pharmacologically active material from dispersing outwardly into the mouth or other regions of the body.
Various modes of carrying out the invention are contemplated as being within the scope of the following claims particularly pointing out and distinctly claiming the subject matter which is regarded as the invention.
We claim:
1. A pressure sensitive dressing for topical application, comprising a solid, flexible hydrated gelatin base capable of maintaining its shape and containing a suflicient amount of pectin to provide initial adhesiveness for application to moist tissue and containing a sufiicient amount of a polyhydric alcohol to maintain flexibility for extended periods, and a generally inert non-toxic fibrous backing member disposed on one surface of said base and serving to prevent the outward dispersion of materials from the base.
2. A dressing for topical applications, comprising a solid, flexible, adhesive, film-like, hydrated gelatin base consisting essentially by weight of 10 to 40% gelatin, 5 to 85% water, 15 to of a polyhydric alcohol, and up to 15% pectin, and a fibrous backing member applied to one surface of the base, said backing member reinforcing the base and serving to prevent the outward dispersion of materials from the base.
3. The structure ofclaim 2, in which the hydrated gelatin base contains up to 10% by weight of a pharmacologically active material, said backing member serving to concentr-ate the pharmacologically active material at the site of treatment and preventing the outward dispersion of said material.
4. The structure ofclaim 2, in which the polyhydric alcohol is selected from the group consisting of glycerin, polyoxyethylene, propylene glycol, ethylene glycol, and sorbitol.
5. The structure of claim 3, in which the backing member is composed of glass fiber fabric.
6. A pressure sensitive dressing for topical applications, comprising a nonflow-able flexible, adhesive, hydrated gelatin sheet consisting essentially by weight of 10 to 33% gelatin, 50 to water, 1 to 4% pectin, 15 to 35% glycerin, and up to 10% of a pharmacologically active material, and a fabric backing member applied to one surface of the hydrated gelatin sheet, said backing member serving to concentrate the pharmacologically active material at the site of treatment and preventing the outward dispersion of said material.
7. The structure of claim 6 in which the hydrated gel-atin sheet also includes from 1 to 2% by weight of alcohol.
8. A dressing for topical applications, comprising a flexible, adhesive, hydrated gelatin base consisting essentially by weight of 10 to 40% gelatin, 5 to 85% Water, 15 to 80% of a polyhydric alcohol, up to 15% pectin and from 10 to 30% by weight of a material selected from the group consisting of lead and barium sulfate, and a fibrous backing member applied to one surface of the base, said backing member reinforcing the base and serving to prevent the outward dispersion of the material from the base, said material serving as a radiation shield to protect portions of the body from radiation.
9. A pressure sensitive article, comprising a flexible, adhesive, hydrated gelatin base containing up to 30% by weight of a radiopaque material, and a fabric backing member applied to one surface of the hydrated gelatin base, said backing member serving to concentrate the radiopaque material at the site of treatment and prevent the outward dispersion of said materiaL-said mtaerial serving as a radiation shield to protect portions of the article from radiation.
References Cited by the Examiner UNITED STATES PATENTS 307,537 11/1884 'Foulks 167 84 335,799 2/ 1886 Baby. 2,115,237 4/1938 Scholl 128268 X 6 Donaldson 1'28156 Shrontz 128-268 Reese.
Hirsch 106-125 Steinhardt 32--2 X FOREIGN PATENTS Germany.
OTHER REFERENCES Macleods Physiology in Modern Medicine, Bard, 8th edition, 1938.
ROBERT E. MORGAN, Primary Examiner.
15 RICHARD A. GAUDET, Examiner.
C. F. ROSENBAUM, Assistant Examiner.

Claims (1)

1. A PRESSURE SENSITIVE DRESSING FOR TOPICAL APPLICATION, COMPRISING A SOLID, FLEXIBLE HYDRATED GELATIN BASE CAPABLE OF MAINTAINING ITS SHAPE AND CONTAINING SUFFICIENT AMOUNT OF PECTIN TO PROVIDE INITIAL ADHESIVENESS FOR APPLICATION TO MOIST TISSUE AND CONTAINING A SUFFICIENT AMOUNT OF A POLYHYDRIC ALCOHOL TO MAINTAIN FLEXIBILITY FOR EXENDED PERIODS, AND A GENERALLY INERT NON-TOXIC FIBROUS BACKING MEMBER DISPOSED ON ONE SURFACE OF SAID BASE AND SERVING TO PREVENT THE OUTWARD DISPERSION OF MATERIALS FROM THE BASE.
US320809A1963-11-011963-11-01Topical dressingExpired - LifetimeUS3249109A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US320809AUS3249109A (en)1963-11-011963-11-01Topical dressing

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US320809AUS3249109A (en)1963-11-011963-11-01Topical dressing

Publications (1)

Publication NumberPublication Date
US3249109Atrue US3249109A (en)1966-05-03

Family

ID=23247955

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US320809AExpired - LifetimeUS3249109A (en)1963-11-011963-11-01Topical dressing

Country Status (1)

CountryLink
US (1)US3249109A (en)

Cited By (108)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3329145A (en)*1965-02-121967-07-04Johnson & JohnsonSanitary napkin having control element with gel-forming material
US3339546A (en)*1963-12-131967-09-05Squibb & Sons IncBandage for adhering to moist surfaces
US3444858A (en)*1965-05-141969-05-20Higham S RussellMethod and means for administering drugs
US3598123A (en)*1969-04-011971-08-10Alza CorpBandage for administering drugs
US3598122A (en)*1969-04-011971-08-10Alza CorpBandage for administering drugs
US3688406A (en)*1970-08-071972-09-05William I PorterApparatus for and method of applying decay retardant compositions to teeth
US3696811A (en)*1971-06-171972-10-10Squibb & Sons IncPeriodontal bandage and backing therefor
US3769071A (en)*1971-06-041973-10-30Minnesota Mining & MfgPressure sensitive adhesive tape comprising 5-fluorouracil
US3960150A (en)*1971-09-091976-06-01Alza CorporationBioerodible ocular device
US3981303A (en)*1971-09-091976-09-21Alza CorporationBioerodible ocular device
US3986510A (en)*1971-09-091976-10-19Alza CorporationBioerodible ocular device
US3993073A (en)*1969-04-011976-11-23Alza CorporationNovel drug delivery device
US3993071A (en)*1971-09-091976-11-23Alza CorporationBioerodible ocular device
US3996934A (en)*1971-08-091976-12-14Alza CorporationMedical bandage
US3998215A (en)*1968-12-181976-12-21Minnesota Mining And Manufacturing CompanyBio-medical electrode conductive gel pads
US4022203A (en)*1976-01-221977-05-10Win AckleyTreated patch for minor cuts
US4062361A (en)*1974-07-081977-12-13Coloplast International A/SBilaminar ostomy sealing disc
US4239488A (en)*1979-06-151980-12-16Sempler Vance AEncapsulated denture adhesive and method of use
US4253460A (en)*1979-07-271981-03-03E. R. Squibb & Sons, Inc.Ostomy adhesive
US4265233A (en)*1978-04-121981-05-05Unitika Ltd.Material for wound healing
US4292299A (en)*1978-11-061981-09-29Teijin LimitedSlow-releasing medical preparation to be administered by adhering to a wet mucous surface
US4306551A (en)*1980-07-281981-12-22Lectec CorporationSterile improved bandage and sealant
US4307717A (en)*1977-11-071981-12-29Lectec CorporationSterile improved bandage containing a medicament
EP0044624A1 (en)*1980-07-091982-01-27E.R. Squibb & Sons, Inc.Lyophilized hydrocolloid foam
US4321252A (en)*1979-08-141982-03-23Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing ester derivatives of estradiol
US4329333A (en)*1980-11-241982-05-11Arthur BarrMethod for the oral treatment of dogs and other animals
US4433960A (en)1981-07-131984-02-28Garito Jon CExtracoronal dental splint and splinting method
US4435180A (en)1982-05-251984-03-06Alza CorporationElastomeric active agent delivery system and method of use
US4460562A (en)*1982-01-061984-07-17Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing propranolol
EP0167263A1 (en)*1984-05-291986-01-08Matrix Pharmaceutical Inc.Drug-containing matrices for introduction into cellular lesion areas
EP0159168A3 (en)*1984-04-051986-01-08Takeda Chemical Industries, Ltd.Soft patch drug preparation
US4631227A (en)*1982-12-081986-12-23Kenji NakamuraToilet article
US4655211A (en)*1984-08-091987-04-07Unitika Ltd.Hemostatic agent
EP0161681A3 (en)*1984-05-171987-04-29Mitsubishi Acetate Co., Ltd.Gel plate and process for preparing same
EP0177920A3 (en)*1984-10-081987-06-03Teijin LimitedPharmaceutical composition for external use containing active type vitam d3
US4728323A (en)*1986-07-241988-03-01Minnesota Mining And Manufacturing CompanyAntimicrobial wound dressings
EP0297828A1 (en)*1987-06-291989-01-04The Kendall CompanyNovel medicated dressings
EP0232580A3 (en)*1986-01-131989-06-21Alza CorporationTransdermal system ii
US4877618A (en)*1988-03-181989-10-31Reed Jr Fred DTransdermal drug delivery device
US4906475A (en)*1988-02-161990-03-06Paco Pharmaceutical ServicesEstradiol transdermal delivery system
US4984570A (en)*1986-04-221991-01-15Karl Otto Braun KgKnitted hydrophobic web wound dressing
US4991574A (en)*1987-07-221991-02-12Dow Corning CorporationSurgical dressing
EP0438749A1 (en)*1990-01-221991-07-31Beiersdorf AktiengesellschaftSelf-adhesive mass from gelatine
US5096715A (en)*1989-11-201992-03-17Alko Ltd.Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
WO1993007928A1 (en)*1991-10-231993-04-29Bioderm, Inc.Medical apparatus fixation and infection control device
US5234957A (en)*1991-02-271993-08-10Noven Pharmaceuticals, Inc.Compositions and methods for topical administration of pharmaceutically active agents
US5332576A (en)*1991-02-271994-07-26Noven Pharmaceuticals, Inc.Compositions and methods for topical administration of pharmaceutically active agents
US5336501A (en)*1989-02-081994-08-09Lohmann Gmbh & Co. KgCross-linked hydrogels and their use as wound dressings
US5437621A (en)*1992-11-191995-08-01Marmon Holdings, Inc.Medical dressing of a multilayered material
EP0666081A1 (en)*1994-01-241995-08-09Bristol-Myers Squibb CompanyWound dressing
US5446070A (en)*1991-02-271995-08-29Nover Pharmaceuticals, Inc.Compositions and methods for topical administration of pharmaceutically active agents
US5480377A (en)*1991-08-071996-01-02New Dimensions In Medicine, Inc.Wound dressing having a roll configuration
US5536263A (en)*1994-03-301996-07-16Lectec CorporationNon-occulusive adhesive patch for applying medication to the skin
EP0852148A1 (en)1991-04-041998-07-08Sion Narrow-WeavingProducts having anti-microbial activity
US5829442A (en)*1996-06-121998-11-03Medical Concepts Development, Inc.Antimicrobial containing solventless hot melt adhesive composition
US6016862A (en)*1996-10-182000-01-25Hormel Foods CorporationCollagen or gelatin crumble composition and uses
US6469227B1 (en)1999-12-102002-10-22Lectec CorporationAntipruritic patch
US20030107149A1 (en)*2001-10-122003-06-12International Fluidics.Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US6664309B2 (en)2000-12-072003-12-16Bostik Findley, Inc.Antimicrobial hot melt adhesive
US20040234605A1 (en)*1996-06-122004-11-25Cox David D.Antimicrobial adhesive system
US20040258896A1 (en)*2001-10-122004-12-23Monosolrx Llc.Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20040258738A1 (en)*2000-12-212004-12-23Kania Bruce G.Treatment devices providing targeted antimicrobial action
US20060039958A1 (en)*2003-05-282006-02-23Monosolrx, Llc.Multi-layer films having uniform content
US20060147493A1 (en)*2002-07-222006-07-06Yang Robert KPackaging and dispensing of rapid dissolve dosage form
US7087269B2 (en)2000-06-232006-08-08Lg Chemical Co., Ltd.Multi-component composite membrane and method for preparing the same
US20070122455A1 (en)*2001-10-122007-05-31Monosolrx, Llc.Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20070149731A1 (en)*2001-10-122007-06-28Monosolrx, Llc.PH modulated films for delivery of actives
US20070154527A1 (en)*2001-10-122007-07-05Monosoirx, LlcTopical film compositions for delivery of actives
US20070172515A1 (en)*2006-01-202007-07-26Monosolrx, LlcFilm bandage for mucosal administration of actives
US20070190157A1 (en)*2006-01-202007-08-16Monosoirx, Llc.Film lined packaging and method of making same
US20070281003A1 (en)*2001-10-122007-12-06Fuisz Richard CPolymer-Based Films and Drug Delivery Systems Made Therefrom
US20080044454A1 (en)*2002-04-112008-02-21Monosolrx LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20080075825A1 (en)*2006-09-202008-03-27Fuisz Richard CEdible Water-Soluble Film Containing a Foam Reducing Flavoring Agent
US20080078413A1 (en)*1996-06-122008-04-03Padget David BSurgical drape
US20080081071A1 (en)*2006-09-292008-04-03Pradeep SanghviFilm Embedded Packaging and Method of Making Same
US20080260809A1 (en)*2002-04-112008-10-23Monosol Rx, LlcPolyethylene oxide-based films and drug delivery systems made therefrom
US20090005443A1 (en)*2007-06-222009-01-01Malcolm Philip YoungTreatment of Depression
WO2009013480A2 (en)2007-07-202009-01-29E-Therapeutics PlcAntibacterial combination therapy
US20100021526A1 (en)*2001-10-122010-01-28Monosol Rx, LlcPh modulated films for delivery of actives
US7666337B2 (en)2002-04-112010-02-23Monosol Rx, LlcPolyethylene oxide-based films and drug delivery systems made therefrom
US20110020217A1 (en)*2007-10-102011-01-27E-Therapeutics PlcTreatment of melanoma
US20110033541A1 (en)*2009-08-072011-02-10Monosol Rx, LlcSublingual and buccal film compositions
US20110033542A1 (en)*2009-08-072011-02-10Monosol Rx, LlcSublingual and buccal film compositions
US20110033376A1 (en)*2007-07-062011-02-10Malcolm Philip YoungTreatment of Melanoma
WO2011030106A1 (en)2009-09-102011-03-17E-Therapeutics PlcCancer cell apoptosis
US20110212173A1 (en)*2008-06-172011-09-01e-Therapeutics PleControlled Release Treatment of Depression
WO2012046006A2 (en)2010-10-082012-04-12University Of DundeeCancer targets
WO2012104589A1 (en)2011-02-022012-08-09University Of EdinburghWeight related disorders
EP2508231A2 (en)2006-11-162012-10-10E-Therapeutics PlcImidazoles for treating multi-drug resistant bacterial infections
WO2013160645A1 (en)2012-04-262013-10-31E-Therapeutics PlcDexanabinol or a derivative thereof for use in the treatment of cancer in dose ranges of 2-30 mg/kg
WO2013164561A1 (en)2012-05-042013-11-07E-Therapeutics PlcTramadol for treating depression
US8614179B2 (en)2008-07-182013-12-24E-Therapeutics PlcAntibacterial combination therapy for the treatment of gram positive bacterial infections
US8663687B2 (en)2001-10-122014-03-04Monosol Rx, LlcFilm compositions for delivery of actives
US8900498B2 (en)2001-10-122014-12-02Monosol Rx, LlcProcess for manufacturing a resulting multi-layer pharmaceutical film
US8900497B2 (en)2001-10-122014-12-02Monosol Rx, LlcProcess for making a film having a substantially uniform distribution of components
US8974826B2 (en)2010-06-102015-03-10Monosol Rx, LlcNanoparticle film delivery systems
WO2015067746A1 (en)2013-11-072015-05-14Bsn Medical GmbhMedical dressing
US9248050B2 (en)2011-10-122016-02-02Roar ConsultantsWound dressing garment
WO2017068349A1 (en)2015-10-232017-04-27E-Therapeutics PlcCannabinoid for use in immunotherapy
US10272607B2 (en)2010-10-222019-04-30Aquestive Therapeutics, Inc.Manufacturing of small film strips
US10285910B2 (en)2001-10-122019-05-14Aquestive Therapeutics, Inc.Sublingual and buccal film compositions
US11077068B2 (en)2001-10-122021-08-03Aquestive Therapeutics, Inc.Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11191737B2 (en)2016-05-052021-12-07Aquestive Therapeutics, Inc.Enhanced delivery epinephrine compositions
US11207805B2 (en)2001-10-122021-12-28Aquestive Therapeutics, Inc.Process for manufacturing a resulting pharmaceutical film
US11273131B2 (en)2016-05-052022-03-15Aquestive Therapeutics, Inc.Pharmaceutical compositions with enhanced permeation
US20220096704A1 (en)*2010-07-222022-03-31Convatec Technologies Inc.Fibres, a process for producing such fibres and a wound dressing incorporating them
US12427121B2 (en)2016-05-052025-09-30Aquestive Therapeutics, Inc.Enhanced delivery epinephrine compositions
US12433850B2 (en)2016-05-052025-10-07Aquestive Therapeutics, Inc.Enhanced delivery epinephrine and prodrug compositions

Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US307537A (en)*1884-11-04Dental capsicum-bag
US335799A (en)*1886-02-09Itnesses
US2115237A (en)*1936-05-111938-04-26William M SchollMedicated button
US2450083A (en)*1944-02-071948-09-28Munising Paper CompanyTreated paper liner for adhesive rolls
US2501544A (en)*1946-10-231950-03-21Shellmar Products CorpTherapeutic product
US2583341A (en)*1950-03-211952-01-22John D ReeseSkin graft receiving member
DE1074979B (en)*1957-02-021960-02-04Fa J H Benecke Hannover Flexible protective material against nuclear, bacterial and chemical weapons,
US2950980A (en)*1958-09-101960-08-30Hirsch ArthurAdhesive compositions
US3029187A (en)*1958-02-201962-04-10Steinhardt AmosGelating adhesive pharmaceutical preparations

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US307537A (en)*1884-11-04Dental capsicum-bag
US335799A (en)*1886-02-09Itnesses
US2115237A (en)*1936-05-111938-04-26William M SchollMedicated button
US2450083A (en)*1944-02-071948-09-28Munising Paper CompanyTreated paper liner for adhesive rolls
US2501544A (en)*1946-10-231950-03-21Shellmar Products CorpTherapeutic product
US2583341A (en)*1950-03-211952-01-22John D ReeseSkin graft receiving member
DE1074979B (en)*1957-02-021960-02-04Fa J H Benecke Hannover Flexible protective material against nuclear, bacterial and chemical weapons,
US3029187A (en)*1958-02-201962-04-10Steinhardt AmosGelating adhesive pharmaceutical preparations
US2950980A (en)*1958-09-101960-08-30Hirsch ArthurAdhesive compositions

Cited By (153)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3339546A (en)*1963-12-131967-09-05Squibb & Sons IncBandage for adhering to moist surfaces
US3329145A (en)*1965-02-121967-07-04Johnson & JohnsonSanitary napkin having control element with gel-forming material
US3444858A (en)*1965-05-141969-05-20Higham S RussellMethod and means for administering drugs
US3998215A (en)*1968-12-181976-12-21Minnesota Mining And Manufacturing CompanyBio-medical electrode conductive gel pads
US3598123A (en)*1969-04-011971-08-10Alza CorpBandage for administering drugs
US3598122A (en)*1969-04-011971-08-10Alza CorpBandage for administering drugs
US3993073A (en)*1969-04-011976-11-23Alza CorporationNovel drug delivery device
US3688406A (en)*1970-08-071972-09-05William I PorterApparatus for and method of applying decay retardant compositions to teeth
US3769071A (en)*1971-06-041973-10-30Minnesota Mining & MfgPressure sensitive adhesive tape comprising 5-fluorouracil
US3696811A (en)*1971-06-171972-10-10Squibb & Sons IncPeriodontal bandage and backing therefor
US3996934A (en)*1971-08-091976-12-14Alza CorporationMedical bandage
US3960150A (en)*1971-09-091976-06-01Alza CorporationBioerodible ocular device
US3981303A (en)*1971-09-091976-09-21Alza CorporationBioerodible ocular device
US3986510A (en)*1971-09-091976-10-19Alza CorporationBioerodible ocular device
US3993071A (en)*1971-09-091976-11-23Alza CorporationBioerodible ocular device
US4062361A (en)*1974-07-081977-12-13Coloplast International A/SBilaminar ostomy sealing disc
US4022203A (en)*1976-01-221977-05-10Win AckleyTreated patch for minor cuts
US4307717A (en)*1977-11-071981-12-29Lectec CorporationSterile improved bandage containing a medicament
US4265233A (en)*1978-04-121981-05-05Unitika Ltd.Material for wound healing
US4292299A (en)*1978-11-061981-09-29Teijin LimitedSlow-releasing medical preparation to be administered by adhering to a wet mucous surface
US4239488A (en)*1979-06-151980-12-16Sempler Vance AEncapsulated denture adhesive and method of use
US4253460A (en)*1979-07-271981-03-03E. R. Squibb & Sons, Inc.Ostomy adhesive
US4321252A (en)*1979-08-141982-03-23Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing ester derivatives of estradiol
US4470962A (en)*1979-08-141984-09-11Key Pharmaceuticals, Inc.Polymeric diffusion matrix
US4492685A (en)*1979-08-141985-01-08Key Pharmaceuticals, Inc.Protective skin matrix
EP0044624A1 (en)*1980-07-091982-01-27E.R. Squibb & Sons, Inc.Lyophilized hydrocolloid foam
US4306551A (en)*1980-07-281981-12-22Lectec CorporationSterile improved bandage and sealant
US4329333A (en)*1980-11-241982-05-11Arthur BarrMethod for the oral treatment of dogs and other animals
US4433960A (en)1981-07-131984-02-28Garito Jon CExtracoronal dental splint and splinting method
US4460562A (en)*1982-01-061984-07-17Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing propranolol
US4435180A (en)1982-05-251984-03-06Alza CorporationElastomeric active agent delivery system and method of use
US4631227A (en)*1982-12-081986-12-23Kenji NakamuraToilet article
US4695465A (en)*1984-04-051987-09-22Takeda Chemical Industry, Ltd.Soft patch
EP0159168A3 (en)*1984-04-051986-01-08Takeda Chemical Industries, Ltd.Soft patch drug preparation
EP0161681A3 (en)*1984-05-171987-04-29Mitsubishi Acetate Co., Ltd.Gel plate and process for preparing same
EP0167263A1 (en)*1984-05-291986-01-08Matrix Pharmaceutical Inc.Drug-containing matrices for introduction into cellular lesion areas
US4655211A (en)*1984-08-091987-04-07Unitika Ltd.Hemostatic agent
EP0177920A3 (en)*1984-10-081987-06-03Teijin LimitedPharmaceutical composition for external use containing active type vitam d3
EP0232580A3 (en)*1986-01-131989-06-21Alza CorporationTransdermal system ii
US4984570A (en)*1986-04-221991-01-15Karl Otto Braun KgKnitted hydrophobic web wound dressing
US4728323A (en)*1986-07-241988-03-01Minnesota Mining And Manufacturing CompanyAntimicrobial wound dressings
EP0297828A1 (en)*1987-06-291989-01-04The Kendall CompanyNovel medicated dressings
US4991574A (en)*1987-07-221991-02-12Dow Corning CorporationSurgical dressing
US4906475A (en)*1988-02-161990-03-06Paco Pharmaceutical ServicesEstradiol transdermal delivery system
US4877618A (en)*1988-03-181989-10-31Reed Jr Fred DTransdermal drug delivery device
US5336501A (en)*1989-02-081994-08-09Lohmann Gmbh & Co. KgCross-linked hydrogels and their use as wound dressings
US5096715A (en)*1989-11-201992-03-17Alko Ltd.Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
EP0438749A1 (en)*1990-01-221991-07-31Beiersdorf AktiengesellschaftSelf-adhesive mass from gelatine
US5234957A (en)*1991-02-271993-08-10Noven Pharmaceuticals, Inc.Compositions and methods for topical administration of pharmaceutically active agents
US5332576A (en)*1991-02-271994-07-26Noven Pharmaceuticals, Inc.Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en)*1991-02-271995-08-29Nover Pharmaceuticals, Inc.Compositions and methods for topical administration of pharmaceutically active agents
EP0852148A1 (en)1991-04-041998-07-08Sion Narrow-WeavingProducts having anti-microbial activity
US5480377A (en)*1991-08-071996-01-02New Dimensions In Medicine, Inc.Wound dressing having a roll configuration
US5207652A (en)*1991-10-231993-05-04BiodermMedical apparatus fixation and infection control device
WO1993007928A1 (en)*1991-10-231993-04-29Bioderm, Inc.Medical apparatus fixation and infection control device
US5437621A (en)*1992-11-191995-08-01Marmon Holdings, Inc.Medical dressing of a multilayered material
EP0666081A1 (en)*1994-01-241995-08-09Bristol-Myers Squibb CompanyWound dressing
US6096334A (en)*1994-03-302000-08-01Lectec CorporationAdhesive patch for applying medication to the skin and method
US5536263A (en)*1994-03-301996-07-16Lectec CorporationNon-occulusive adhesive patch for applying medication to the skin
US5741510A (en)*1994-03-301998-04-21Lectec CorporationAdhesive patch for applying analgesic medication to the skin
US6096333A (en)*1994-03-302000-08-01Lectec CorporationMethod of forming adhesive patch for applying medication to the skin
US20080220067A1 (en)*1996-06-122008-09-11Cox David DAntimicrobial adhesive system
US20100227937A1 (en)*1996-06-122010-09-09Cox David DAntimicrobial adhesive system
US6607746B2 (en)1996-06-122003-08-19Medical Concepts Development, Inc.Antimicrobial containing solventless hot melt adhesive composition
US20040234605A1 (en)*1996-06-122004-11-25Cox David D.Antimicrobial adhesive system
US5829442A (en)*1996-06-121998-11-03Medical Concepts Development, Inc.Antimicrobial containing solventless hot melt adhesive composition
US20080078413A1 (en)*1996-06-122008-04-03Padget David BSurgical drape
US6090915A (en)*1996-10-182000-07-18Hormel Foods CorporationCollagen or gelatin crumble composition and uses
US6016862A (en)*1996-10-182000-01-25Hormel Foods CorporationCollagen or gelatin crumble composition and uses
US6469227B1 (en)1999-12-102002-10-22Lectec CorporationAntipruritic patch
US7087269B2 (en)2000-06-232006-08-08Lg Chemical Co., Ltd.Multi-component composite membrane and method for preparing the same
US6664309B2 (en)2000-12-072003-12-16Bostik Findley, Inc.Antimicrobial hot melt adhesive
US20040258738A1 (en)*2000-12-212004-12-23Kania Bruce G.Treatment devices providing targeted antimicrobial action
US7157614B1 (en)2000-12-212007-01-02Fountainhead, LlcTreatment devices providing targeted antimicrobial action
US20070069416A1 (en)*2001-10-122007-03-29Monosolrx, LlcThin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US7425292B2 (en)2001-10-122008-09-16Monosol Rx, LlcThin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8663687B2 (en)2001-10-122014-03-04Monosol Rx, LlcFilm compositions for delivery of actives
US20070122455A1 (en)*2001-10-122007-05-31Monosolrx, Llc.Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20070149731A1 (en)*2001-10-122007-06-28Monosolrx, Llc.PH modulated films for delivery of actives
US20070154527A1 (en)*2001-10-122007-07-05Monosoirx, LlcTopical film compositions for delivery of actives
US8685437B2 (en)2001-10-122014-04-01Monosol Rx, LlcThin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8765167B2 (en)2001-10-122014-07-01Monosol Rx, LlcUniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20070281003A1 (en)*2001-10-122007-12-06Fuisz Richard CPolymer-Based Films and Drug Delivery Systems Made Therefrom
US8900498B2 (en)2001-10-122014-12-02Monosol Rx, LlcProcess for manufacturing a resulting multi-layer pharmaceutical film
US8900497B2 (en)2001-10-122014-12-02Monosol Rx, LlcProcess for making a film having a substantially uniform distribution of components
US20050184427A1 (en)*2001-10-122005-08-25Monosolrx, Llc.Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8906277B2 (en)2001-10-122014-12-09Monosol Rx, LlcProcess for manufacturing a resulting pharmaceutical film
US7357891B2 (en)2001-10-122008-04-15Monosol Rx, LlcProcess for making an ingestible film
US20040258896A1 (en)*2001-10-122004-12-23Monosolrx Llc.Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US9931305B2 (en)2001-10-122018-04-03Monosol Rx, LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20080260805A1 (en)*2001-10-122008-10-23Monosol Rx, LlcThin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US9108340B2 (en)2001-10-122015-08-18Monosol Rx, LlcProcess for manufacturing a resulting multi-layer pharmaceutical film
US9855221B2 (en)2001-10-122018-01-02Monosol Rx, LlcUniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7910641B2 (en)2001-10-122011-03-22Monosol Rx, LlcPH modulated films for delivery of actives
US11207805B2 (en)2001-10-122021-12-28Aquestive Therapeutics, Inc.Process for manufacturing a resulting pharmaceutical film
US20090181069A1 (en)*2001-10-122009-07-16Monosol Rx, LlcThin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20100021526A1 (en)*2001-10-122010-01-28Monosol Rx, LlcPh modulated films for delivery of actives
US8652378B1 (en)2001-10-122014-02-18Monosol Rx LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20030107149A1 (en)*2001-10-122003-06-12International Fluidics.Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US7824588B2 (en)2001-10-122010-11-02Monosol Rx, LlcMethod of making self-supporting therapeutic active-containing film
US11077068B2 (en)2001-10-122021-08-03Aquestive Therapeutics, Inc.Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10888499B2 (en)2001-10-122021-01-12Aquestive Therapeutics, Inc.Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US10285910B2 (en)2001-10-122019-05-14Aquestive Therapeutics, Inc.Sublingual and buccal film compositions
US7666337B2 (en)2002-04-112010-02-23Monosol Rx, LlcPolyethylene oxide-based films and drug delivery systems made therefrom
US8603514B2 (en)2002-04-112013-12-10Monosol Rx, LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8017150B2 (en)2002-04-112011-09-13Monosol Rx, LlcPolyethylene oxide-based films and drug delivery systems made therefrom
US20080260809A1 (en)*2002-04-112008-10-23Monosol Rx, LlcPolyethylene oxide-based films and drug delivery systems made therefrom
US10111810B2 (en)2002-04-112018-10-30Aquestive Therapeutics, Inc.Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20080044454A1 (en)*2002-04-112008-02-21Monosolrx LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20060147493A1 (en)*2002-07-222006-07-06Yang Robert KPackaging and dispensing of rapid dissolve dosage form
US20060039958A1 (en)*2003-05-282006-02-23Monosolrx, Llc.Multi-layer films having uniform content
US20070190157A1 (en)*2006-01-202007-08-16Monosoirx, Llc.Film lined packaging and method of making same
US20070172515A1 (en)*2006-01-202007-07-26Monosolrx, LlcFilm bandage for mucosal administration of actives
US7972618B2 (en)2006-09-202011-07-05Monosol Rx, LlcEdible water-soluble film containing a foam reducing flavoring agent
US20080075825A1 (en)*2006-09-202008-03-27Fuisz Richard CEdible Water-Soluble Film Containing a Foam Reducing Flavoring Agent
US20080081071A1 (en)*2006-09-292008-04-03Pradeep SanghviFilm Embedded Packaging and Method of Making Same
EP2508231A2 (en)2006-11-162012-10-10E-Therapeutics PlcImidazoles for treating multi-drug resistant bacterial infections
US20090005443A1 (en)*2007-06-222009-01-01Malcolm Philip YoungTreatment of Depression
EP2014282A2 (en)2007-06-222009-01-14E-Therapeutics plcTreatment of depression
US20110033376A1 (en)*2007-07-062011-02-10Malcolm Philip YoungTreatment of Melanoma
EP2529733A1 (en)2007-07-202012-12-05E-Therapeutics PlcAntibacterial combination therapy
WO2009013480A2 (en)2007-07-202009-01-29E-Therapeutics PlcAntibacterial combination therapy
US20110039906A1 (en)*2007-07-202011-02-17E-Therapeutics PlcAntibacterial combination therapy
EP2529737A1 (en)2007-07-202012-12-05E-Therapeutics plcAntibacterial combination therapy
US20110020217A1 (en)*2007-10-102011-01-27E-Therapeutics PlcTreatment of melanoma
US20110212173A1 (en)*2008-06-172011-09-01e-Therapeutics PleControlled Release Treatment of Depression
US8614179B2 (en)2008-07-182013-12-24E-Therapeutics PlcAntibacterial combination therapy for the treatment of gram positive bacterial infections
US11135216B2 (en)2009-08-072021-10-05Indivior Uk LimitedSublingual and buccal film compositions
US20110033542A1 (en)*2009-08-072011-02-10Monosol Rx, LlcSublingual and buccal film compositions
US8475832B2 (en)2009-08-072013-07-02Rb Pharmaceuticals LimitedSublingual and buccal film compositions
US20110033541A1 (en)*2009-08-072011-02-10Monosol Rx, LlcSublingual and buccal film compositions
US9687454B2 (en)2009-08-072017-06-27Indivior Uk LimitedSublingual and buccal film compositions
US10821074B2 (en)2009-08-072020-11-03Aquestive Therapeutics, Inc.Sublingual and buccal film compositions
US10034833B2 (en)2009-08-072018-07-31Aquestive Therapeutics, Inc.Sublingual and buccal film compositions
WO2011030106A1 (en)2009-09-102011-03-17E-Therapeutics PlcCancer cell apoptosis
US8974826B2 (en)2010-06-102015-03-10Monosol Rx, LlcNanoparticle film delivery systems
US20220096704A1 (en)*2010-07-222022-03-31Convatec Technologies Inc.Fibres, a process for producing such fibres and a wound dressing incorporating them
US11878083B2 (en)*2010-07-222024-01-23Convatec Technologies Inc.Fibres, a process for producing such fibres and a wound dressing incorporating them
WO2012046006A2 (en)2010-10-082012-04-12University Of DundeeCancer targets
US10272607B2 (en)2010-10-222019-04-30Aquestive Therapeutics, Inc.Manufacturing of small film strips
US10940626B2 (en)2010-10-222021-03-09Aquestive Therapeutics, Inc.Manufacturing of small film strips
WO2012104589A1 (en)2011-02-022012-08-09University Of EdinburghWeight related disorders
US9795516B2 (en)2011-10-122017-10-24Roar ConsultantsWound dressing garment
US9248050B2 (en)2011-10-122016-02-02Roar ConsultantsWound dressing garment
WO2013160645A1 (en)2012-04-262013-10-31E-Therapeutics PlcDexanabinol or a derivative thereof for use in the treatment of cancer in dose ranges of 2-30 mg/kg
WO2013164561A1 (en)2012-05-042013-11-07E-Therapeutics PlcTramadol for treating depression
WO2015067746A1 (en)2013-11-072015-05-14Bsn Medical GmbhMedical dressing
WO2017068349A1 (en)2015-10-232017-04-27E-Therapeutics PlcCannabinoid for use in immunotherapy
US11191737B2 (en)2016-05-052021-12-07Aquestive Therapeutics, Inc.Enhanced delivery epinephrine compositions
US11273131B2 (en)2016-05-052022-03-15Aquestive Therapeutics, Inc.Pharmaceutical compositions with enhanced permeation
US12023309B2 (en)2016-05-052024-07-02Aquestive Therapeutics, Inc.Enhanced delivery epinephrine compositions
US12427121B2 (en)2016-05-052025-09-30Aquestive Therapeutics, Inc.Enhanced delivery epinephrine compositions
US12433850B2 (en)2016-05-052025-10-07Aquestive Therapeutics, Inc.Enhanced delivery epinephrine and prodrug compositions

Similar Documents

PublicationPublication DateTitle
US3249109A (en)Topical dressing
US3328259A (en)Dressing for a wound containing a hemostatic agent and method of treating a wound
JP3575817B2 (en) Extrudable compositions for topical or transdermal drug delivery
US3339546A (en)Bandage for adhering to moist surfaces
US20080027365A1 (en)Hemostatic device with oxidized cellulose pad
EP0072251B1 (en)Improved bandage containing a medicament
AU781878C (en)Use of honey in medical dressings
US9333117B2 (en)Clay-based hemostatic agents and devices for the delivery thereof
ES2229254T3 (en) STRUCTURED CONTRACT OCLUSIVE.
US4307717A (en)Sterile improved bandage containing a medicament
US3347236A (en)Disposable article having a layer of artificial absorbent fibers and supporting sheet
US3698392A (en)Topical dressing
US2804424A (en)Method of preparing a tetracycline type antibiotic-containing wound dressing
JPS5948409A (en)Promotor for orthodontic tooth mobility
JP2003526387A (en) Disposable absorbent product with skin adhesive
EP0297828A1 (en)Novel medicated dressings
JPS63153068A (en)Adhesive article
JP2003225298A (en) Adhesive plaster
JPH03141229A (en)Composition and drug for treating wound
WO1986002270A1 (en)Cough-relieving compositions
CN221490421U (en) A dressing patch
RU203792U1 (en) Trauma First Aid Device
JPS62112557A (en)Patch agent for external application
JP3308628B2 (en) Medical patch
JPH06145047A (en)Hydrous skin patch for external use having improved utility

[8]ページ先頭

©2009-2025 Movatter.jp